Princeton Global Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-650
| Closed | -$64.2K | – | 692 |
|
|
2024
Q3 | $64.2K | Hold |
650
| – | – | 0.01% | 287 |
|
|
2024
Q2 | $60.3K | Hold |
650
| – | – | 0.01% | 269 |
|
|
2024
Q1 | $61.7K | Hold |
650
| – | – | 0.01% | 237 |
|
|
2023
Q4 | $58K | Hold |
650
| – | – | 0.01% | 246 |
|
|
2023
Q3 | $47.5K | Sell |
650
-500
| -43% | -$36.5K | 0.01% | 258 |
|
|
2023
Q2 | $95.7K | Hold |
1,150
| – | – | 0.03% | 202 |
|
|
2023
Q1 | $87.6K | Hold |
1,150
| – | – | 0.03% | 215 |
|
|
2022
Q4 | $95K | Hold |
1,150
| – | – | 0.03% | 190 |
|
|
2022
Q3 | $91K | Hold |
1,150
| – | – | 0.03% | 194 |
|
|
2022
Q2 | $85K | Hold |
1,150
| – | – | 0.03% | 211 |
|
|
2022
Q1 | $103K | Hold |
1,150
| – | – | 0.03% | 202 |
|
|
2021
Q4 | $129K | Buy |
+1,150
| New | +$129K | 0.04% | 192 |
|